Carole Cagnot

1.8k total citations
19 papers, 192 citations indexed

About

Carole Cagnot is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Carole Cagnot has authored 19 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Hepatology and 2 papers in Physiology. Recurrent topics in Carole Cagnot's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (9 papers). Carole Cagnot is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (9 papers). Carole Cagnot collaborates with scholars based in France, Switzerland and Canada. Carole Cagnot's co-authors include Pierre Nahon, Richard Layese, Olivier Séror, Julie Bulsei, Charlotte Costentin, Isabelle Rosa, Karine Chevreul, Alexis Laurent, Benjamin Cadier and Isabelle Durand‐Zaleski and has published in prestigious journals such as Hepatology, Journal of Hepatology and Nutrients.

In The Last Decade

Carole Cagnot

17 papers receiving 188 citations

Peers

Carole Cagnot

HEPAT

EPIDE

ONCOL

Natalie C. Fisher United Kingdom

Vasileios Lekakis Greece

Taku Shigesawa Japan

Ane Zamalloa United Kingdom

Alisa Likhitsup United States

Samir R. Shah India

Chengxiao Yu China

R. A. de Vries Netherlands

Natalie C. Fisher United Kingdom

Carole Cagnot

101 ×0.8

HEPAT

107 ×1.0

EPIDE

55 ×1.9

ONCOL

14 ×0.7

40 ×2.2

Citations per year, relative to Carole Cagnot Carole Cagnot (= 1×) peers Natalie C. Fisher

Countries citing papers authored by Carole Cagnot

Since Specialization

Citations

This map shows the geographic impact of Carole Cagnot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Cagnot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Cagnot more than expected).

Fields of papers citing papers by Carole Cagnot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Cagnot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Cagnot. The network helps show where Carole Cagnot may publish in the future.

Co-authorship network of co-authors of Carole Cagnot

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Cagnot. A scholar is included among the top collaborators of Carole Cagnot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Cagnot. Carole Cagnot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Barré, Tangui, Marc Bourlière, Lucia Parlati, et al.. (2023). Hepatitis C virus cure from direct‐acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort). Drug and Alcohol Review. 43(3). 718–731.

Dorival, Céline, Carole Cagnot, Hélène Fontaine, et al.. (2022). Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response. Clinics and Research in Hepatology and Gastroenterology. 46(6). 101923–101923. 14 indexed citations

Coilly, Audrey, Mylène Sebagh, Claire Fougerou‐Leurent, et al.. (2022). HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation. Clinics and Research in Hepatology and Gastroenterology. 46(9). 102024–102024.

Carrieri, Patrizia, Fabrice Carrat, Marc Bourlière, et al.. (2022). Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors. JHEP Reports. 4(6). 100481–100481. 6 indexed citations

Fontaine, Hélène, Nathanaël Lapidus, Clovis Lusivika‐Nzinga, et al.. (2022). Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort. Journal of Viral Hepatitis. 30(3). 232–241. 4 indexed citations

Barré, Tangui, Hélène Fontaine, Stanislas Pol, et al.. (2022). Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort). Clinical Nutrition. 41(3). 610–619. 14 indexed citations

Fontaine, Hélène, Nathanaël Lapidus, Céline Dorival, et al.. (2022). Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers. Journal of Hepatology. 77. S17–S18. 2 indexed citations

Allavena, Clotilde, Hubert Blain, Laurence Slama, et al.. (2022). Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older. AIDS. 37(1). 183–189. 12 indexed citations

Fontaine, Hélène, Nathanaël Lapidus, Céline Dorival, et al.. (2022). Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers. Pharmacoepidemiology and Drug Safety. 32(4). 486–495. 11 indexed citations

10.

Barré, Tangui, Marc Bourlière, Fabrice Carrat, et al.. (2022). Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort). Journal of Clinical Medicine. 11(20). 6135–6135. 5 indexed citations

11.

Nahon, Pierre, Richard Layese, Carole Cagnot, et al.. (2021). HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management. Cancer Prevention Research. 14(5). 581–592. 1 indexed citations

12.

Nahon, Pierre, et al.. (2020). Profiling of routine serum parameters and AFP evolution in cirrhosis following HCVeradication for stratification of HCC risk: a trajectory clustering analysis from the ANRS CO12 CirVir cohort. Journal of Hepatology. 73. S22–S22. 1 indexed citations

13.

Ganne‐Carrié, Nathalie, Céline Dorival, Carole Cagnot, et al.. (2020). Predictive models for hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C and sustained virological response (SVR) achieved with direct acting anti-viral (DAA) included in the ANRS CO22 hepather cohort. Journal of Hepatology. 73. S106–S106. 2 indexed citations

14.

Zarski, Jean‐Pierre, Sandra David‐Tchouda, Candice Trocmé, et al.. (2019). Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis. Clinics and Research in Hepatology and Gastroenterology. 44(4). 524–531. 6 indexed citations

15.

Bastard, Jean‐Philippe, Soraya Fellahi, Étienne Audureau, et al.. (2018). Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis. European Cytokine Network. 29(3). 112–120. 7 indexed citations

16.

Wendum, Dominique, Richard Layese, Nathalie Ganne‐Carrié, et al.. (2018). Influence of Progenitor‐Derived Regeneration Markers on Hepatitis C Virus–Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort). Hepatology. 68(4). 1534–1548. 7 indexed citations

17.

Buscail, Camille, Valérie Bourcier, Léopold Fezeu, et al.. (2018). Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study. Nutrients. 10(1). 60–60. 10 indexed citations

18.

Cacoub, P., Pierre Nahon, Richard Layese, et al.. (2017). HCV eradication reduces the occurrence of major adverse cardiovascular events in hepatitis C cirrhotic patients: data from the prospective ANRS CO12 CirVir cohort. Journal of Hepatology. 66(1). S20–S21. 3 indexed citations

19.

Cadier, Benjamin, Julie Bulsei, Pierre Nahon, et al.. (2017). Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States. Hepatology. 65(4). 1237–1248. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact